Mycoplasma fermentans—Induced Inflammatory Response of Astrocytes: Selective Modulation by Aminoguanidine, Thalidomide, Pentoxifylline and IL-10

[1]  E. Brahn,et al.  The effect of thalidomide and 2 analogs on collagen induced arthritis. , 1998, The Journal of rheumatology.

[2]  A. Ahmed,et al.  Interleukin-10: biology, role in inflammation and autoimmunity. , 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  R. Sobel,et al.  Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. , 1997, Journal of immunology.

[4]  G. Kaplan,et al.  Thalidomide as an anti-TNF-α inhibitor: Implications for clinical use , 1996 .

[5]  P. Shrikant,et al.  The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. , 1996, Journal of immunology.

[6]  S. Galli,et al.  The Regulation of Tumor Necrosis Factor-α Production in Murine Mast Cells: Pentoxifylline or Dexamethasone Inhibits IgE-Dependent Production of TNF-α by Distinct Mechanisms , 1996 .

[7]  Peng Wang,et al.  Interleukin (IL)-10 Inhibits Nuclear Factor B (NFB) Activation in Human Monocytes , 1995, The Journal of Biological Chemistry.

[8]  A. Avron,et al.  Mycoplasma stimulates the production of oxidative radicals by murine peritoneal macrophages , 1995, Journal of leukocyte biology.

[9]  R. Gallily,et al.  Cytokines induced in vitro by Mycoplasma mycoides ssp. mycoides, large colony type. , 1995, Veterinary immunology and immunopathology.

[10]  D. Hanley,et al.  Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains , 1994, Annals of neurology.

[11]  R. Gallily,et al.  Mycoplasma triggering of nitric oxide production by central nervous system glial cells and its inhibition by glucocorticoids , 1994, Brain Research.

[12]  H. Tilg,et al.  IMMUNE RESPONSE MODULATION BY PENTOXIFYLLINE IN VITRO , 1993, Transplantation.

[13]  G. Kaplan,et al.  Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation , 1993, The Journal of experimental medicine.

[14]  T. Brenner,et al.  Age-Dependent Sensitivity of Cultured Rat Glial Cells to Bilirubin Toxicity , 1993, Experimental Neurology.

[15]  O. Abramsky,et al.  Stimulation of tumor necrosis factor-α production by mycoplasmas and inhibition by dexamethasone in cultured astrocytes , 1993, Brain Research.

[16]  S. Rottem,et al.  Mycoplasma fermentans (incognitus strain) induces TNF alpha and IL-1 production by human monocytes and murine macrophages. , 1992, Immunology letters.

[17]  Y. Vodovotz,et al.  Macrophage deactivation by interleukin 10 , 1991, The Journal of experimental medicine.

[18]  A. Reder,et al.  Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis , 1991, Journal of Neuroimmunology.

[19]  G. Kaplan,et al.  Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes , 1991, The Journal of experimental medicine.

[20]  Jiahuai Han,et al.  Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway , 1990, The Journal of experimental medicine.

[21]  H. Alter,et al.  Identification of Mycoplasma incognitus infection in patients with AIDS: an immunohistochemical, in situ hybridization and ultrastructural study. , 1989, The American journal of tropical medicine and hygiene.

[22]  R. Gallily,et al.  Tumor necrosis factor as a mediator of Mycoplasma orale-induced tumor cell lysis by macrophages. , 1989, Cellular immunology.

[23]  J. Sidtis,et al.  The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. , 1988, Science.

[24]  D. Silberberg,et al.  Astrocytes, oligodendrocytes, and Schwann cells share a common antigenic determinant that cross-reacts with myelin basic protein: identification with monoclonal antibody , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[25]  Kenny Ge,et al.  Mycoplasmas as agents of human disease. , 1981 .

[26]  G. Cassell,et al.  Mycoplasmas as agents of human disease. , 1981, The New England journal of medicine.

[27]  S. Rottem,et al.  Mycoplasma capricolum membranes induce tumor necrosis factor α by a mechanism different from that of lipopolysaccharide , 2005, Cancer Immunology, Immunotherapy.

[28]  S. Galli,et al.  The regulation of tumor necrosis factor-alpha production in murine mast cells: pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-alpha by distinct mechanisms. , 1996, Cellular immunology.

[29]  G. Kaplan,et al.  SHORT ANALYTICAL REVIEW Thalidomide as an Anti-TNF-a Inhibitor: Implications for Clinical Use , 1996 .

[30]  M. Billah,et al.  Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. , 1995, The Journal of biological chemistry.

[31]  S. Razin,et al.  Molecular and diagnostic procedures in mycoplasmology , 1995 .